Using a compound from a centuries-old Chinese traditional medicine, Yale University researcher Dr. Craig Crews has been able to prevent the formation of kidney-destroying cysts in a mouse model of polycystic kidney disease.
When bile duct cancer cells were placed in the liver of animals with bile duct obstruction, they grew more rapidly than identical cells placed in animals without bile duct obstruction. In fact, half of the total liver mass of the rats with bile duct obstruction became replaced by cancer cells within three weeks compared to only 16 percent of that of animals without bile duct obstruction.
As a national supporter of Cover the Uninsured Week, the American Public Health Association (APHA) renews its call for expanding health coverage for children through Medicaid and the State Children?s Health Insurance Program (SCHIP).
Access to antiretroviral therapy for advanced HIV infection in low- and middle-income countries continued to grow throughout 2006, with more than two million people living with HIV/AIDS receiving treatment in December 2006, a 54% increase over the 1.3 million people on treatment one year earlier in these countries.
Indian Government has proposed to encourage setting up of stand-alone health insurance companies, which could provide cover even for routine OPD treatment in hospitals and nursing homes without getting admitted.
UK Health Minister Andy Burnham published new guidance to help health bodies and practitioners deliver high quality convenient care closer to people’s homes.
Lord Hunt announced that the UK Department of Health has asked the cosmetic surgery industry to work on improving safety in the cosmetic use of botulinum toxin and dermal fillers.
A UK collaboration of scientists has identified three new genes that predispose individuals to develop type 2 diabetes 1, bringing scientists a step closer towards understanding what causes this complex disease.
Almost half of sales visits by pharmaceutical company representatives advocating the use of the drug gabapentin led to doctors stating that they intended to increase their prescription of the drug or recommend it to colleagues, according to an analysis of a survey completed by the doctors shortly after the visits.
Pfizer Canada Inc. announced that Health Canada has approved the cholesterol-lowering therapy Lipitor(R) (atorvastatin calcium) to reduce the risk of myocardial infarction in patients with clinically evident coronary heart disease.